Pattern Pharma
Founded Year
2018Stage
Unattributed - V | AliveTotal Raised
$7.86MLast Raised
$3.92M | 1 yr agoAbout Pattern Pharma
Pattern Pharma is an immunotherapy company whose PAR-1 product activates the innate immune system, thereby targeting the immune failure which lies at the root of many diseases, including cancers and infectious diseases.
Compete with Pattern Pharma?
Ensure that your company and products are accurately represented on our platform.
Pattern Pharma's Products & Differentiators
P2PAR-100
P2PAR-100, is a Toll-like receptor 4 (TLR4) agonist which has been shown to be a potent immune-potentiator with broad potential applicability to oncology indications with high unmet need.
Expert Collections containing Pattern Pharma
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Pattern Pharma is included in 3 Expert Collections, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Regenerative Medicine
1,818 items
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
Latest Pattern Pharma News
Sep 29, 2021
Pattern Pharma, a Toronto-based immunotherapy company focused on combating cancer and infectious disease, has collected C$5 million in financing.
Pattern Pharma Frequently Asked Questions (FAQ)
When was Pattern Pharma founded?
Pattern Pharma was founded in 2018.
Where is Pattern Pharma's headquarters?
Pattern Pharma's headquarters is located at 31 Ridge Dr., Toronto.
What is Pattern Pharma's latest funding round?
Pattern Pharma's latest funding round is Unattributed - V.
How much did Pattern Pharma raise?
Pattern Pharma raised a total of $7.86M.
What products does Pattern Pharma offer?
Pattern Pharma's products include P2PAR-100.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.